Results 41 to 50 of about 74,097 (190)
: Background: Parkinson's disease is a neurodegenerative disorder, and a major cause of disability. Levodopa, a prodrug of dopamine, remains the gold standard in the pharmacological management of Parkinson's disease.
Benedicta Obenewaa Dankyi, MPhil+5 more
doaj
Adsorption of levodopa from aqueous solution on granular activated carbon [PDF]
Granular activated carbon filtration has been successfully used in wastewater and drinking water treatment plants, for removal of different pollutants and it is the most efficient conventional treatment method for the purification of water contaminated ...
Delmas, Henri+4 more
core
Functional correlates of optic flow motion processing in Parkinson’s disease [PDF]
The visual input created by the relative motion between an individual and the environment, also called optic flow, influences the sense of self-motion, postural orientation, veering of gait, and visuospatial cognition.
Cronin-Golomb, Alice+6 more
core +5 more sources
Qualitative evaluation of adherence therapy in Parkinson’s disease: a multidirectional model [PDF]
Background: Medication can control the symptoms of Parkinson’s disease (PD). Despite this, non-adherence with medication is prevalent in PD. Treatments for improving adherence with medication have been investigated in many chronic conditions, including ...
Daley, David+4 more
core +2 more sources
Expanding the spectrum of impulse control disorders in Parkinson's disease: the phenomenology of sweet craving [PDF]
Thesis (M.A.)--Boston UniversityBackground: The recognized spectrum of impulse control disorders in Parkinson’s disease (PD) includes pathologic gambling, hypersexuality, compulsive buying, and binge eating, and is commonly related to exposure to ...
Brown, Caitlin Harrington
core +1 more source
Acting without being in control: Exploring volition in Parkinson's disease with impulsive compulsive behaviours. [PDF]
BACKGROUND: Several aspects of volitional control of action may be relevant in the pathophysiology of impulsive-compulsive behaviours (ICB) in Parkinson's disease (PD).
de Boer, L+6 more
core +2 more sources
Background. Rasagiline is a selective, irreversible monoamine oxidase type B inhibitor used as monotherapy in early Parkinson’s disease and as an adjunct therapy to levodopa in Parkinson’s disease with motor fluctuations. Objectives.
Osamu Kano+3 more
doaj +1 more source
Mortality in Parkinson's disease : A systematic review and meta-analysis [PDF]
© 2014 International Parkinson and Movement Disorder Society.Peer reviewedPublisher ...
Greenland S+3 more
core +1 more source
David J BrooksDivision of Neuroscience, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, UKAbstract: After 40 years of clinical experience, levodopa remains the gold standard treatment for Parkinson’s disease (PD) despite ...
David J Brooks
doaj
The impact of motor symptoms on self-reported anxiety in Parkinson's disease [PDF]
OBJECTIVE: Anxiety is commonly endorsed in Parkinson's disease (PD) and significantly affects quality of life. The Beck Anxiety Inventory (BAI) is often used but contains items that overlap with common PD motor symptoms (e.g., “hands trembling”). Because
Cronin-Golomb, A.+3 more
core +1 more source